Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G B Ferrara

Showing results (41-50 of 150) with videos related to

Pageof 15
Sort By:
The Journal of Experimental Medicine|December 1, 1978
Immunological dissection of human Ia moleculesR Tosi, N Tanigaki, D Centis, et al.
Immunogenetics|January 1, 1983
The distribution of DR5, MT2, and MB3 specificities on human Ia subsetsN Tanigaki, R Tosi, K Sagawa, et al.
Human Immunology|October 1, 1981
Further characterization of two "DR supertypic" specificities. Additional evidence that they reside on molecules different from those carrying HLA-DR locus specificitiesN Tanigaki, R Tosi, D Centis, et al.
Human Immunology|November 1, 1991
Frequency of DPB1*0401 is significantly decreased in patients with allergic asthma in a mulatto populationL Caraballo, J Marrugo, S Jimenez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1984
Serologically detectable polymorphism of the HLA-DC alpha-subunitR Tosi, N Tanigaki, R Sorrentino, et al.
Tissue Antigens|August 25, 2000
Identification of a new DRB3*02 allelic variant (DRB3*0209) by high-resolution sequence-based typingA Morabito, C Pera, A Longo, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|April 1, 1993
Shared epitopes of the HLA-DR10 molecule recognized by murine and human mAbsM P Pistillo, P F Sun, S Mantero, et al.
Bone Marrow Transplantation|August 1, 1992
Analysis of chimerism after bone marrow transplantation using specific oligonucleotide probesL Casarino, C Carbone, M A Capucci, et al.
Tissue Antigens|April 25, 2000
Molecular characterization and applications of recombinant scFv antibodies to CD152 co-stimulatory moleculeM P Pistillo, P L Tazzari, J H Ellis, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1993
HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cellsM Colonna, G Borsellino, M Falco, et al.
Pageof 15

Showing results (41-50 of 150) with videos related to

Sort By:
Pageof 15
The Journal of Experimental Medicine|December 1, 1978
Immunological dissection of human Ia moleculesR Tosi, N Tanigaki, D Centis, et al.
Immunogenetics|January 1, 1983
The distribution of DR5, MT2, and MB3 specificities on human Ia subsetsN Tanigaki, R Tosi, K Sagawa, et al.
Human Immunology|October 1, 1981
Further characterization of two "DR supertypic" specificities. Additional evidence that they reside on molecules different from those carrying HLA-DR locus specificitiesN Tanigaki, R Tosi, D Centis, et al.
Human Immunology|November 1, 1991
Frequency of DPB1*0401 is significantly decreased in patients with allergic asthma in a mulatto populationL Caraballo, J Marrugo, S Jimenez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1984
Serologically detectable polymorphism of the HLA-DC alpha-subunitR Tosi, N Tanigaki, R Sorrentino, et al.
Tissue Antigens|August 25, 2000
Identification of a new DRB3*02 allelic variant (DRB3*0209) by high-resolution sequence-based typingA Morabito, C Pera, A Longo, et al.
European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics|April 1, 1993
Shared epitopes of the HLA-DR10 molecule recognized by murine and human mAbsM P Pistillo, P F Sun, S Mantero, et al.
Bone Marrow Transplantation|August 1, 1992
Analysis of chimerism after bone marrow transplantation using specific oligonucleotide probesL Casarino, C Carbone, M A Capucci, et al.
Tissue Antigens|April 25, 2000
Molecular characterization and applications of recombinant scFv antibodies to CD152 co-stimulatory moleculeM P Pistillo, P L Tazzari, J H Ellis, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 15, 1993
HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cellsM Colonna, G Borsellino, M Falco, et al.
Pageof 15